The Congress of the European Committee for Treatment and Research in Multiple Sclerosis is the world’s largest annual international conference devoted to basic and clinical research in multiple sclerosis. After a new record participation with over 9’000 delegates from 95 countries already in Barcelona last year, the 32nd ECTRIMS taking place in London (UK) from 14 to 17 September 2016 promises to be even more successful.
Abstract submission is now closed and ECTRIMS is excited to announce that 1985 submissions have been received, an increase of 10% to the previous congress.
The abstract review has begun, and the submitters are expected to receive an answer regarding the abstract’s acceptance by the end of June 2016.
The 2016 Congress will be the first ever held in the United Kingdom, a country that has contributed much to research and treatment in MS. Many excellent UK-based scientists and clinicians have focused their career on MS.
The Congress will offer comprehensive and exciting scientific and teaching programmes. There will be plenary, platform, young investigator, hot topic (some in a debate format) and poster sessions. Themes will include disease mechanisms, prognostic markers, developments in imaging, approaches to early treatment, long term treatment effects, the latest clinical trial results, and emerging targets for modulation of the innate immune system, neuroprotection and repair. While MS is the main focus, there will be talks on other inflammatory demyelinating CNS diseases. There will be a special section of the programme for MS nurses and symposia sponsored by the European Charcot Foundation and industry. The meeting will also partner with the Annual Conference of Rehabilitation in MS (RIMS).
The Congress will be held at the ExCeL Centre, a modern state-of- the-art facility in east London and close by the London City Airport, which has direct connections to many destinations throughout Europe.